embCAB sequence variation among ethambutol-resistant Mycobacterium tuberculosis isolates without embB306 mutation
about
Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosisDiscovery and development of SQ109: a new antitubercular drug with a novel mechanism of action.A joint cross-border investigation of a cluster of multidrug-resistant tuberculosis in Austria, Romania and Germany in 2014 using classic, genotyping and whole genome sequencing methods: lessons learnt.Re-evaluation of the critical concentration for ethambutol antimicrobial sensitivity testing on the MGIT 960.Sequence analysis for detection of first-line drug resistance in Mycobacterium tuberculosis strains from a high-incidence settingDiversity of Mycobacterium tuberculosis and drug resistance in different provinces of Papua New GuineaCharacteristics of embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates in Henan, ChinaGenotypic characterization of drug resistant Mycobacterium tuberculosis in Quebec, 2002-2012.Evaluation of MTBDRplus and MTBDRsl in Detecting Drug-Resistant Tuberculosis in a Chinese Population.Inhibition of the first step in synthesis of the mycobacterial cell wall core, catalyzed by the GlcNAc-1-phosphate transferase WecA, by the novel caprazamycin derivative CPZEN-45Mutations Found in embCAB, embR, and ubiA Genes of Ethambutol-Sensitive and -Resistant Mycobacterium tuberculosis Clinical Isolates from China.Molecular and Growth-Based Drug Susceptibility Testing of Mycobacterium tuberculosis Complex for Ethambutol Resistance in the United StatesembB306 mutations as molecular indicators to predict ethambutol susceptibility in Mycobacterium tuberculosis.Mutations within embCAB Are Associated with Variable Level of Ethambutol Resistance in Mycobacterium tuberculosis Isolates from China.
P2860
Q27342229-0377C053-3C02-4CB1-8430-D06F83A5FE73Q30419537-78294DE7-A0BF-4327-BB29-A0EB08B73B1AQ33601686-CC26DE70-C083-40AF-A1E9-1357580570D2Q34259008-0909A57C-6FBE-40F3-9A67-FD2CA02A4C01Q34286080-D93F5269-CD36-44FE-8B50-D5B098E0E390Q34687487-8C3915E7-8E1A-4928-B668-9AFF9E79A7D2Q35210458-AEADE491-5E16-495B-8A98-0EF4DEE502A8Q36086220-C2B6CEFB-486C-4B30-A459-FC78DBFDEE6AQ37156901-106F8436-A43A-47AB-A518-1DFCE135AE19Q37234023-F77527F6-04F4-45D9-A205-589876A5A635Q40487996-813DA9D4-0A6F-46BB-BC57-509B089E2CF0Q42577091-1E2098D9-CD42-4786-A127-7A9E3218040FQ46639370-7D39036E-8C78-4B0B-BFE8-C81F48B1AD67Q47587138-4865D829-4895-4D77-A220-30F84AAFD989
P2860
embCAB sequence variation among ethambutol-resistant Mycobacterium tuberculosis isolates without embB306 mutation
description
im April 2010 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 28 April 2010
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2010
@uk
name
embCAB sequence variation amon ...... lates without embB306 mutation
@en
embCAB sequence variation amon ...... lates without embB306 mutation
@nl
type
label
embCAB sequence variation amon ...... lates without embB306 mutation
@en
embCAB sequence variation amon ...... lates without embB306 mutation
@nl
prefLabel
embCAB sequence variation amon ...... lates without embB306 mutation
@en
embCAB sequence variation amon ...... lates without embB306 mutation
@nl
P2093
P2860
P356
P1476
embCAB sequence variation amon ...... lates without embB306 mutation
@en
P2093
Claudia Plinke
Hamraev A Karimovich
Kai Braker
Nana Zarkua
Roland Diel
Sabine Rüsch-Gerdes
Silke Feuerriegel
Stefan Niemann
P2860
P304
P356
10.1093/JAC/DKQ120
P407
P50
P577
2010-04-28T00:00:00Z